ArticleThe journal of allergy and clinical immunology. Global2026
Cycling biologic therapy with tezepelumab and mepolizumab for eosinophilic otitis media and eosinophilic pneumonia in a patient with asthma.
Osamu Matsuno et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.